Weiliqing^® Entecavir dispersible tablets / capsules is a nucleoside analogue used for antiviral treatment of chronic hepatitis B. It has many advantages, such as low resistance rates, strong antiviral activity, and the ability to significantly suppress HBV replication, making it highly effective for treating chronic hepatitis B in adults. Long-term treatment with Weiliqing^® Entecavir can suppress HBV DNA replication, continuously improve histology, and reverse liver fibrosis and cirrhosis. It is a first-line recommended antiviral drug in both domestic and international authoritative guidelines.